the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Drug Delivery Technologies: Controlled-release Players, products & prospects to 2018

Published by Espicom Business Intelligence Contact us : +1-860-674-8796
Published 2009/06 Content info 126 Pages
Product code ES94090
Price From  US $ 1130 Order/Price list
US $ 1130 Hard Copy
US $ 1130 PDF by E-mail (Single User License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

EXECUTIVE SUMMARY & INTRODUCTION

  • Overview of controlled-release delivery: past, present & future
  • Controlled delivery profiles
  • Controlled-release delivery: motivators & resistors
  • Controlled-release delivery: impact on product lifecycles

CONTROLLED-RELEASE DELIVERY

  • Types of controlled-release delivery used
    • Activated controlled-release delivery
    • Degradation controlled-release delivery
    • Diffusion controlled-release delivery
  • Current therapeutic application of controlled-release in drug delivery
  • Leading brands that utilise controlled-release delivery
  • Future commercial applications & opportunities

STRATEGIES OF DRUG DELIVERY COMPANIES

  • Leading controlled-release drug delivery companies
  • Partnerships & acquisitions
  • Intellectual Property

THE CONTROLLED-RELEASE MARKET

  • Now 2009: Approved controlled-release product sales
  • Future 2018: Global controlled-release product sales and novel controlled-release product sales

COMPETITOR ANALYSIS

  • Detailed analysis of leading companies covering:
  • Proprietary delivery technology
  • Applications in the pharma industry
  • Management/technical expertise
  • Competition within the delivery technology sector
  • Products in development/approved utilising the delivery technology
  • Sales forecasts of products utilising the delivery technology
  • Competitor ratio analysis

Companies analysed:

  • AlphaRx Corporation
  • ALZA Corporation
  • Antares Pharma, Inc.
  • Biovail Corporation
  • Camurus AB
  • Cerulean Pharma, Inc
  • Cipher Pharmaceuticals, Inc.
  • Debiopharm Group
  • DelSite Biotechnologies, Inc.
  • Depomed, Inc.
  • Durect Corporation
  • Elan Corporation
  • Elite Pharmaceuticals, Inc.
  • Endo Pharmaceuticals, Inc.
  • Ethypharm SA
  • Eurand N.V.
  • Flamel Technologies, Inc.
  • Glycologic, Ltd
  • KV Pharmaceuticals, Inc
  • Labopharm, Inc.
  • Lavipharm SA
  • Nano Interface Technology
  • OctoPlus N.V.
  • Penwest Pharmaceuticals, Inc.
  • SCOLR Pharma, Inc.
  • Shire, Plc.
  • Skinvisible, Inc.
  • SkyePharma, Inc.
  • Spherics Pharmaceuticals, Inc.
  • Watson Pharmaceuticals, Inc.

APPENDICIES

  • Global controlled release approved drug sales 2008-2018
  • Global controlled release development drug sales 2008-2018
  • Key controlled release delivery companies by 2015
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.